Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pola Chemical Industries is the research and manufacturing core of the Pola Orbis Group, a leading Japanese beauty and health conglomerate. Founded in 1929, the company specializes in the development and production of high-performance cosmetics, quasi-drugs, and health foods. It is renowned for its advanced dermatological research, particularly in the fields of anti-aging and skin brightening, and was the first to receive Japanese regulatory approval for a quasi-drug active ingredient (NEI-L1) specifically for wrinkle improvement. The company operates an integrated value chain from basic research to mass production, utilizing state-of-the-art facilities in Yokohama and Shizuoka. Pola Chemical Industries also engages in open innovation through global collaborations with institutions like MIT and A*STAR to explore the intersection of skin science, neuroscience, and well-being.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pola Chemical Industries.